Quantitative motor readouts as provided by QuantiMedis have been used in
the following clinical trials / studies:
-
CAFQ056A2207 in Huntington's disease Sponsor: Novartis Pharma, Basel, Switzerland
(EUDRACT2009-011743-39/NCT01019473)
-
CAQW051A2209 in Parkinson's disease Sponsor: Novartis Pharma, Basel,
witzerland (EUDRACT2011-001092-39/NCT01474421)
-
ACTION-HD in Huntington's disease Sponsor: Charité Berlin,
Germany (EUDRACT2009-013698-16)
-
ETON in Huntington's disease Sponsor: Charité Berlin,
Germany (EUDRCCT2010-023941-31/NCT01357681)
-
TRACK-HD in Huntington's disease Sponsor: CHDI Foundation,
New York, USA
-
TRACK-ON-HD in Huntington's disease Sponsor: CHDI Foundation,
New York, USA
-
PREDICT-HD in Huntington's disease Sponsor: NIH, Bethesda B.
CHDI Foundation, New York, USA